As per the company’s management, its FY27 new hospital earnings before interest, taxes, depreciation and amortization (EBITDA) loss is guided at ₹140 crore to ₹150 crore and is unchanged from its March quarter call.
The digital vertical is guided to reach breakeven in the upcoming quarter, it said.
Apollo Hospitals’ insurance business is expected to reach breakeven by the third quarter of this fiscal, as per the management.
It is also targeting the diagnostics business to reach 20% margin over the next six to eight quarters.
The expansion through FY31 will be funded largely via internal accruals. The management has reiterated a comfortable balance sheet debt position.
Apollo Hospitals, on Wednesday, reported its first quarter earnings, which beat Street expectations across all key parameters.
The company’s net profit came in at ₹610 crore compared to the CNBC-TV18 poll of ₹553 crore. It was also 38.4% above last year’s ₹441 crore.The company’s revenue increased to ₹7,044 crore from ₹6,923 crore projected by the poll. It was also 20.6% more than Street estimates of ₹5,842 crore.
The company’s earnings before interest, taxes, depreciation and amortization (EBITDA) increased to ₹1,092 crore from Street estimates of ₹1,038 crore and was up 28.2% from the ₹852 crore it reported in the June quarter last year.
Its margin expanded to 15.5% from Street estimates of 15% and from 14.6% in the year-ago period.
Shares of Apollo Hospitals gained 3.6% to hit an intraday high of ₹8,910 apiece on Friday. The stock has was up 3.2% at ₹8,874 apiece at 11.40 am. It has declined 0.4% in the past month but has risen 24.7% this year, so far.
Also Read: Zee Entertainment shares surge 7% as SAT stays SEBI order
